Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19

To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe coronavirus disease 2019 (COVID‐19). A total of 27 patients with severe COVID‐19 who were admitted to Tongji Hospital in Wuhan from 1 to 21 February 2020 were recruited to the study. The characteristics of interleukin‐1β (IL‐1β), IL‐2 receptor (IL‐2R), IL‐6, IL‐8, IL‐10, tumor necrosis factor‐α (TNF)‐α, C‐reactive protein (CRP), serum ferritin and procalcitonin (PCT), and lymphocyte subsets of these patients were retrospectively compared before and after treatment. Before treatment, there was no significant difference in most inflammatory factors (IL‐1β, IL‐2R, IL‐6, IL‐8, IL‐10, CRP, and serum ferritin) between male and female patients. Levels of IL‐2R, IL‐6, TNF‐α, and CRP decreased significantly after treatment, followed by IL‐8, IL‐10, and PCT. Serum ferritin was increased in all patients before treatment but did not decrease significantly after treatment. IL‐1β was normal in most patients before treatment. Lymphopenia was common among these patients with severe COVID‐19. Analysis of lymphocyte subsets showed that CD4+ and particularly CD8+ T lymphocytes increased significantly after treatment. However, B lymphocytes and natural killer cells showed no significant changes after treatment. A pro‐inflammatory response and decreased level of T lymphocytes were associated with severe COVID‐19.

[1]  F. Swirski,et al.  Cytokine storm and sepsis disease pathogenesis , 2017, Seminars in Immunopathology.

[2]  Dong Wei,et al.  Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score , 2019, Front. Microbiol..

[3]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[4]  C. Leport,et al.  Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France , 2015, Clinical Microbiology and Infection.

[5]  M. Roberts,et al.  Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature , 2018, Pharmacotherapy.

[6]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[7]  Nam-Hyuk Cho,et al.  Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity , 2016, Scientific Reports.

[8]  T. Croghan,et al.  Transgenic mice lacking class I major histocompatibility complex- restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge , 1992, The Journal of experimental medicine.

[9]  C. Coopersmith,et al.  TAT-BH4 and TAT-Bcl-xL Peptides Protect against Sepsis-Induced Lymphocyte Apoptosis In Vivo1 , 2006, The Journal of Immunology.

[10]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[11]  J. Baillie,et al.  Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.

[12]  T. Fung,et al.  Human Coronavirus: Host-Pathogen Interaction. , 2019, Annual review of microbiology.

[13]  Y. Guan,et al.  Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.

[14]  Jianping Wu,et al.  Serum ferritin concentration predicts mortality in patients with hepatitis B virus-related acute on chronic liver failure. , 2014, Archives of medical research.

[15]  D. Swerdlow,et al.  Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.

[16]  M. Netea,et al.  IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections , 2016, PLoS pathogens.

[17]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[18]  P. Conti,et al.  Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. , 2020, Journal of biological regulators and homeostatic agents.

[19]  T. Yue,et al.  Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. , 1995, Atherosclerosis.

[20]  J. Chan,et al.  Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong , 2006, Journal of Infection.

[21]  M. Huang,et al.  Combination of lymphocyte number and function in evaluating host immunity , 2019, Aging.

[22]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[23]  Rajaa Al-Raddadi,et al.  Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome , 2017, American journal of respiratory and critical care medicine.

[24]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[25]  H. Uzun,et al.  Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase , 2018, Archives of medical science : AMS.

[26]  Qibo Zhang,et al.  MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile , 2018, Cytokine.

[27]  M. Chan-yeung,et al.  High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. , 2003, American journal of respiratory and critical care medicine.

[28]  T. Auyeung,et al.  The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study , 2004, Journal of Infection.

[29]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[30]  T. Yue,et al.  Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells , 1995 .

[31]  P. Conti,et al.  Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. , 2019, Journal of biological regulators and homeostatic agents.

[32]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[33]  Ali Danesh,et al.  Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.

[34]  J. Houtman,et al.  Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections , 2018, PLoS pathogens.

[35]  Paul Garner,et al.  SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.

[36]  Gianpaolo Ronconi,et al.  Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. , 2020 .

[37]  R. Chambers,et al.  The mercurial nature of neutrophils: still an enigma in ARDS? , 2014, American journal of physiology. Lung cellular and molecular physiology.

[38]  K. Subbarao,et al.  Innate and adaptive T cells in influenza disease , 2018, Frontiers of Medicine.

[39]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.

[40]  Byung Geun Kim,et al.  A comparison of the BISAP score and serum procalcitonin for predicting the severity of acute pancreatitis , 2013, The Korean journal of internal medicine.

[41]  M. Netea,et al.  Hyperferritinaemia in Dengue Virus Infected Patients Is Associated with Immune Activation and Coagulation Disturbances , 2014, PLoS neglected tropical diseases.

[42]  F. Torti,et al.  Serum ferritin: Past, present and future. , 2010, Biochimica et biophysica acta.

[43]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[44]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[45]  R. Soundravally,et al.  Ferritin levels predict severe dengue , 2015, Infection.

[46]  M. Brennen,et al.  PROFILE , 2004 .

[47]  K. Subbarao,et al.  The Immunobiology of SARS*. , 2007, Annual review of immunology.

[48]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[49]  C. Coopersmith,et al.  Accelerated Lymphocyte Death in Sepsis Occurs by both the Death Receptor and Mitochondrial Pathways1 , 2005, The Journal of Immunology.

[50]  P. Conti,et al.  How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. , 2020, Journal of biological regulators and homeostatic agents.

[51]  D. Heymann,et al.  COVID-19: what is next for public health? , 2020, The Lancet.